VeriMomoligopeptide-15 hamilelikte güvenli mi?
No evidence found of reproductive or developmental toxicity for oligopeptide-15 in available regulatory sources. There is no harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment flagging reproductive risk. Peptides of this type are generally large, enzymatically degraded and have low dermal/systemic bioavailability when used topically, supporting negligible exposure in pregnancy (sources searched: ECHA Annex VI, SCCS/CIR, PubChem, PubMed, CosIng, EWG).
Related ingredients
Frequently asked questions
- oligopeptide-15 hamilelikte güvenli mi?
- No evidence found of reproductive or developmental toxicity for oligopeptide-15 in available regulatory sources. There is no harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment flagging reproductive risk. Peptides of this type are generally large, enzymatically degraded and have low dermal/systemic bioavailability when used topically, supporting negligible exposure in pregnancy (sources searched: ECHA Annex VI, SCCS/CIR, PubChem, PubMed, CosIng, EWG).
- oligopeptide-15 emzirirken güvenli mi?
- No data indicating maternal reproductive or lactation hazards or transfer into breast milk. No harmonised classification or safety assessment (ECHA Annex VI, SCCS, CIR). Topical peptides are typically poorly absorbed and rapidly metabolised, so systemic exposure sufficient for significant breast milk transfer is unlikely (sources searched: PubMed, PubChem, CosIng, EWG).
- oligopeptide-15 bebek cildi için güvenli mi?
- No hazard or mechanism evidence specific to infants. However, infant skin has an immature barrier and higher surface-area-to-weight ratio; where an ingredient has any measurable dermal absorption in adults, exposure for 0–3 yr olds is typically increased. For oligopeptide-15 there are no reported reproductive/toxic findings, so hazard and mechanism are scored 0, but exposure is increased by +1 for baby skin precaution (sources searched: PubMed, PubChem, CosIng, EWG; no SCCS/CIR/ECHA harmonised concerns found).
- VeriMom oligopeptide-15 nasıl puanlıyor?
- VeriMom oligopeptide-15'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte oligopeptide-15 yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.